Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates

Nitrogen-containing-bisphosphonates (N-BPs) are a class of drugs widely prescribed to treat osteoporosis and other bone-related diseases. Although previous studies have established that N-BPs function by inhibiting the mevalonate pathway in osteoclasts, the mechanism by which N-BPs enter the cytosol...

Full description

Bibliographic Details
Main Authors: Wyant, Gregory A, Abu-Remaileh, Monther, Sabatini, David M.
Other Authors: Whitehead Institute for Biomedical Research
Format: Article
Language:English
Published: eLife Sciences Publications, Ltd 2020
Subjects:
Online Access:https://hdl.handle.net/1721.1/124751
_version_ 1826206043786444800
author Wyant, Gregory A
Abu-Remaileh, Monther
Sabatini, David M.
author2 Whitehead Institute for Biomedical Research
author_facet Whitehead Institute for Biomedical Research
Wyant, Gregory A
Abu-Remaileh, Monther
Sabatini, David M.
author_sort Wyant, Gregory A
collection MIT
description Nitrogen-containing-bisphosphonates (N-BPs) are a class of drugs widely prescribed to treat osteoporosis and other bone-related diseases. Although previous studies have established that N-BPs function by inhibiting the mevalonate pathway in osteoclasts, the mechanism by which N-BPs enter the cytosol from the extracellular space to reach their molecular target is not understood. Here, we implemented a CRISPRi-mediated genome-wide screen and identified SLC37A3 (solute carrier family 37 member A3) as a gene required for the action of N-BPs in mammalian cells. We observed that SLC37A3 forms a complex with ATRAID (all-trans retinoic acid-induced differentiation factor), a previously identified genetic target of N-BPs. SLC37A3 and ATRAID localize to lysosomes and are required for releasing N-BP molecules that have trafficked to lysosomes through fluid-phase endocytosis into the cytosol. Our results elucidate the route by which N-BPs are delivered to their molecular target, addressing a key aspect of the mechanism of action of N-BPs that may have significant clinical relevance.
first_indexed 2024-09-23T13:23:07Z
format Article
id mit-1721.1/124751
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T13:23:07Z
publishDate 2020
publisher eLife Sciences Publications, Ltd
record_format dspace
spelling mit-1721.1/1247512022-09-28T13:48:55Z Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates Wyant, Gregory A Abu-Remaileh, Monther Sabatini, David M. Whitehead Institute for Biomedical Research Massachusetts Institute of Technology. Department of Biology Koch Institute for Integrative Cancer Research at MIT General Biochemistry, Genetics and Molecular Biology General Immunology and Microbiology General Neuroscience General Medicine Nitrogen-containing-bisphosphonates (N-BPs) are a class of drugs widely prescribed to treat osteoporosis and other bone-related diseases. Although previous studies have established that N-BPs function by inhibiting the mevalonate pathway in osteoclasts, the mechanism by which N-BPs enter the cytosol from the extracellular space to reach their molecular target is not understood. Here, we implemented a CRISPRi-mediated genome-wide screen and identified SLC37A3 (solute carrier family 37 member A3) as a gene required for the action of N-BPs in mammalian cells. We observed that SLC37A3 forms a complex with ATRAID (all-trans retinoic acid-induced differentiation factor), a previously identified genetic target of N-BPs. SLC37A3 and ATRAID localize to lysosomes and are required for releasing N-BP molecules that have trafficked to lysosomes through fluid-phase endocytosis into the cytosol. Our results elucidate the route by which N-BPs are delivered to their molecular target, addressing a key aspect of the mechanism of action of N-BPs that may have significant clinical relevance. 2020-04-21T12:15:25Z 2020-04-21T12:15:25Z 2018-05-10 2020-01-29T16:30:58Z Article http://purl.org/eprint/type/JournalArticle 2050-084X https://hdl.handle.net/1721.1/124751 Yu, Zhou , et al. “Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates.” eLife 7 (2018): e36620 © 2018 The Author(s) en 10.7554/elife.36620 eLife Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf eLife Sciences Publications, Ltd eLife
spellingShingle General Biochemistry, Genetics and Molecular Biology
General Immunology and Microbiology
General Neuroscience
General Medicine
Wyant, Gregory A
Abu-Remaileh, Monther
Sabatini, David M.
Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
title Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
title_full Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
title_fullStr Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
title_full_unstemmed Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
title_short Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
title_sort identification of a transporter complex responsible for the cytosolic entry of nitrogen containing bisphosphonates
topic General Biochemistry, Genetics and Molecular Biology
General Immunology and Microbiology
General Neuroscience
General Medicine
url https://hdl.handle.net/1721.1/124751
work_keys_str_mv AT wyantgregorya identificationofatransportercomplexresponsibleforthecytosolicentryofnitrogencontainingbisphosphonates
AT aburemailehmonther identificationofatransportercomplexresponsibleforthecytosolicentryofnitrogencontainingbisphosphonates
AT sabatinidavidm identificationofatransportercomplexresponsibleforthecytosolicentryofnitrogencontainingbisphosphonates